Other
NAVA ventilation
NAVA ventilation is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed133%
unknown133%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Neurally Adjusted Ventilatory Assist (NAVA) Study in Adults With Acute Respiratory Failure
NCT01730794
unknownnot_applicable
Physiological Response in Lung Transplant Recipients Undergoing Neurally Adjusted Ventilatory Assist
NCT03367221
withdrawnnot_applicable
Impact of PAV Versus NAVA on Patient-Ventilator Synchrony and Respiratory Muscle Unloading
NCT01810510
Clinical Trials (3)
Showing 3 of 3 trials
NCT01730794Not Applicable
Neurally Adjusted Ventilatory Assist (NAVA) Study in Adults With Acute Respiratory Failure
NCT03367221Not Applicable
Physiological Response in Lung Transplant Recipients Undergoing Neurally Adjusted Ventilatory Assist
NCT01810510Not Applicable
Impact of PAV Versus NAVA on Patient-Ventilator Synchrony and Respiratory Muscle Unloading
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3